Cargando…

MAFLD and ASCVD: Plasma Heparin Cofactor II Activity as an Anti-liver Fibrosis Biomarker

Detalles Bibliográficos
Autor principal: Shimabukuro, Michio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406663/
https://www.ncbi.nlm.nih.gov/pubmed/36740275
http://dx.doi.org/10.5551/jat.ED227
_version_ 1785085793301168128
author Shimabukuro, Michio
author_facet Shimabukuro, Michio
author_sort Shimabukuro, Michio
collection PubMed
description
format Online
Article
Text
id pubmed-10406663
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Japan Atherosclerosis Society
record_format MEDLINE/PubMed
spelling pubmed-104066632023-08-09 MAFLD and ASCVD: Plasma Heparin Cofactor II Activity as an Anti-liver Fibrosis Biomarker Shimabukuro, Michio J Atheroscler Thromb Editorial Japan Atherosclerosis Society 2023-08-01 2023-02-04 /pmc/articles/PMC10406663/ /pubmed/36740275 http://dx.doi.org/10.5551/jat.ED227 Text en 2023 Japan Atherosclerosis Society https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Editorial
Shimabukuro, Michio
MAFLD and ASCVD: Plasma Heparin Cofactor II Activity as an Anti-liver Fibrosis Biomarker
title MAFLD and ASCVD: Plasma Heparin Cofactor II Activity as an Anti-liver Fibrosis Biomarker
title_full MAFLD and ASCVD: Plasma Heparin Cofactor II Activity as an Anti-liver Fibrosis Biomarker
title_fullStr MAFLD and ASCVD: Plasma Heparin Cofactor II Activity as an Anti-liver Fibrosis Biomarker
title_full_unstemmed MAFLD and ASCVD: Plasma Heparin Cofactor II Activity as an Anti-liver Fibrosis Biomarker
title_short MAFLD and ASCVD: Plasma Heparin Cofactor II Activity as an Anti-liver Fibrosis Biomarker
title_sort mafld and ascvd: plasma heparin cofactor ii activity as an anti-liver fibrosis biomarker
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406663/
https://www.ncbi.nlm.nih.gov/pubmed/36740275
http://dx.doi.org/10.5551/jat.ED227
work_keys_str_mv AT shimabukuromichio mafldandascvdplasmaheparincofactoriiactivityasanantiliverfibrosisbiomarker